Clinical Smecta new uses.docVIP

 PAGE \* MERGEFORMAT 7 Clinical Smecta new uses [Keywords:] new use for pediatric Smecta Smectite is the main component of double-octahedral smectite, silica by the double-tetrahedron composed of one octahedral alumina multi-layer structure. On the gastrointestinal mucous membrane covered with a strong ability to protect mucous membranes, inhibition of virus bacteria and their toxins. can be used to treat esophagitis, gastritis and peptic ulcers, especially due to various reasons, acute and chronic diarrhea has a good effect. With its increasingly widespread in clinical application, found in the Clinical Pediatrics also the increasing number of new uses are summarized below. 1 prevention of gastrointestinal side effects of erythromycin Ruanxian Li [1] reported that infusion of erythromycin in children treated 76 patients, aged 8 to 12 years old. 38 patients were randomly divided into two groups, control group 38 patients. The treatment group 30 min before taking erythromycin infusion think density of granules 3.0 g, control group not taking Smecta. two groups of the same concentration of erythromycin intravenous drip rate the same. the same way as the primary disease treatment in both groups. Results: There were no adverse reactions observed in 22 cases, 12 mild adverse reactions cases of severe adverse reactions in 4 cases, the control group had no adverse reactions in 5 cases, mild adverse reactions in 9 cases, 24 cases of severe adverse reactions. Observer Group of serious gastrointestinal adverse reactions was significantly lower than the control group (P lt;0.01. When large doses of intravenous erythromycin can motilin levels in plasma increased with the motility of gastrointestinal smooth muscle receptors produced a strong contraction of abdominal pain, nausea, vomiting, diarrhea and other gastrointestinal side effects . Smecta on the gastrointestinal mucosa has a strong reach, combined with the mucus, improving mucosal barrier defenses of